Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

STRYKER CORP Director's Dealing 2023

Jan 12, 2023

29816_dirs_2023-01-11_806c1777-4b4d-4481-803f-2af4335b2f88.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: STRYKER CORP (SYK)
CIK: 0000310764
Period of Report: 2023-01-09

Reporting Person: Fink M Kathryn (VP, Chief HR Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-01-09 Common Stock S 3536 $260 Disposed 9264 Direct
2023-01-10 Common Stock M 1397 $93.06 Acquired 10661 Direct
2023-01-10 Common Stock M 5174 $96.64 Acquired 15835 Direct
2023-01-11 Common Stock S 1158 $256.4898 Disposed 14677 Direct
2023-01-11 Common Stock S 3417 $257.3019 Disposed 11260 Direct
2023-01-11 Common Stock S 1403 $258.4492 Disposed 9857 Direct
2023-01-11 Common Stock S 346 $259.4873 Disposed 9511 Direct
2023-01-11 Common Stock S 116 $261.1212 Disposed 9395 Direct
2023-01-11 Common Stock S 131 $262.7188 Disposed 9264 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2023-01-10 Employee Stock Option granted 02/11/2015 (right to buy) $93.06 M 1397 Disposed 2025-02-10 Common Stock (1397.0) Direct
2023-01-10 Employee Stock Option granted 02/10/2016 (right to buy) $96.64 M 5174 Disposed 2026-02-09 Common Stock (5174.0) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 342 Indirect

Footnotes

F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 11, 2022.

F2: Includes 26 shares of Stryker Common Stock acquired pursuant to Stryker Corporation's Employee Stock Purchase Plan ("ESPP") as of December 31, 2022, the date of the latest available statement of the reporting person's ESPP holdings.

F3: The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $255.81 to $256.78, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.

F4: The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $256.85 to $257.835, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.

F5: The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $257.855 to $258.82, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.

F6: The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $259.105 to $259.65, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.

F7: The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $260.46 to $261.23, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.

F8: The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $262.67 to $263, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.

F9: Employee stock option granted pursuant to the Stryker Corporation 2011 Long-Term Incentive Plan, exercisable as to 20% on each of the first five anniversaries of the date of grant.